Tag Archives: ARNA
Biotech Movers In Reviews; Abbott (NYSE:ABT) Results Up- ABT, PPHM, ITMN, GILD, AMGN
Abbott Laboratories (NYSE:ABT), drug and medical device maker declared on Wednesday that it has higher Q3 profit, topping analyst anticipations, even as revenue plunged. The firm, which is in the process of following-up several of its businesses, also eliminating 550 … Continue reading
Posted in FINANCE NEWS
Tagged Abbott Laboratories, ABT, Amgen, AMGN, ARNA, GILD, Gilead Sciences, InterMune, NASDAQ:AMGN, NASDAQ:GILD, NASDAQ:ITMN, NASDAQ:PPHM, NYSE:ABT, Peregrine Pharmaceuticals, PPHM
Leave a comment
Day Gainers at US Market Giving Big Returns to Investors
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) advanced 28.70% to settle at $11.39 with overall traded volume of 90.26 million shares its average volume is 25.08 million shares. The market capitalization of company was $2.08 billion and outstanding shares of the company are 182.50 … Continue reading
Posted in STOCKS IN FOCUS
Tagged Arena Pharmaceuticals, ARNA, Lincare Holdings, LNCR, Loral Space & Communications, LORL, NASDAQ:ARNA, NASDAQ:LNCR, NASDAQ:LORL
Leave a comment
Investors Alert; Surging Stocks Giving More Return to Day Traders
Onyx Pharmaceuticals, Inc.(NASDAQ:ONXX) reported a boost of 43.07% to settle at $63.78 with overall traded volume of 22.78 million shares its average volume is 1.47 million shares. The market capitalization of company was $4.11 billion and outstanding shares of the … Continue reading
Day Movers at Healthcare Sector
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) advanced 73.77% to settle at $6.36 with overall traded volume of 76.66 million shares its average volume is 16.03 shares. The market capitalization of company was $1.16 billion and outstanding shares of the company are 182.50 … Continue reading
Posted in STOCKS IN FOCUS
Tagged Arena Pharmaceuticals, ARNA, NASDAQ:ARNA, NASDAQ:OREX, NASDAQ:RPRX, OREX, Orexigen Therapeutics, Repros Therapeutics, RPRX
Leave a comment
Investors Alert; Surging Stocks Giving More Return to Day Traders
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a boost of 25.74% to settle at $3.42 with overall traded volume of 50.71 million shares its average volume is 15.55 million shares. Gross profit margin of the company was 40.73%. The market capitalization of … Continue reading
Posted in STOCKS IN FOCUS
Tagged Arena Pharmaceuticals, ARNA, Generac Holdings, GNRC, NASDAQ:ARNA, NASDAQ:SVNT, NYSE:GNRC, Savient Pharmaceuticals, SVNT
Leave a comment
